American Herbal Products Association (AHPA) > News > Alerts > Market Alerts

Market Alerts

December 2018

November 2018

October 2018

September 2018

August 2018

July 2018

May 2018

April 2018

March 2018

February 2018

January 2018

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017

Dr. Mark Plotkin to keynote AHPA Annual Member Meeting and Breakfast at Expo West

Dr. Mark Plotkin to keynote AHPA Annual Member Meeting and Breakfast at Expo West

Industry insights, board of trustees' election, and the 2018 AHPA Awards

Wednesday, March 6, 2018 from 7:30 AM to 12:00 PM at Expo West in Anaheim, CA

USDA’s final rule for GMO labeling ignores recommendations of consumers and AHPA

Final rule hinders consumer access to information on genetically modified foods

The U.S. Department of Agriculture (USDA) Agricultural Marketing Service (AMS) issued a final rule on December 20 that establishes the new national mandatory bioengineered (BE) food disclosure standard. The final rule does not incorporate significant revisions recommended by AHPA and consumer groups that were aimed at ensuring U.S. consumers can discern if their food includes genetically modified organisms (GMOs) or ingredients derived from GMOs.

FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Two-part webinar recorded Dec. 4 and 18

Two-part webinar will provide data on recent FDA inspections, an overview of emerging compliance issues and strategies for responding to an FDA 483 in order to avoid an FDA warning letter.

Nutritional supplements access preserved in Arizona

AHPA and NPA protect proper rules for safe, legal, natural products

A proposal that would have drastically limited access to safe, legal and popular products for Arizonans was changed recently thanks to the Natural Products Association (NPA) and the American Herbal Products Association (AHPA), who worked with the Arizona Board of Pharmacy and other state policymakers on the issue.
Lessons in herb safety from The Cleveland Clinic Chinese Herbal Medicine Program

Lessons in herb safety from The Cleveland Clinic Chinese Herbal Medicine Program

Clinic reports only six mild adverse events since 2014

Nationally board-certified acupuncturist and Chinese herbalist at the Cleveland Clinic Galina Roofener shared safety data and lessons learned from the Cleveland Clinic Wellness Institute’s Traditional Chinese Herbal Medicine (TCHM) Program at her keynote delivered at the American Herbal Products Association’s (AHPA’s) 7th Annual Botanical Congress presented on Nov. 10 in Las Vegas at the SupplySide West trade show.

Dietary Supplement Trade Associations Warn Consumers of Dangerous Substance Illegally Posing as a Dietary Supplement

Supplement industry sounds the alarm about the dangers of “phenibut,” a substance being illegally marketed in products fraudulently labeled as dietary supplements

Developed and used as a drug in the former Soviet Union for its supposed brain-enhancing properties, phenibut is not approved as a drug in the United States, nor does it meet the regulatory requirements to be sold in, or as, a dietary supplement. The ingredient should be considered dangerous, and has been associated with potentially serious side effects and great risk for addiction.

AHPA corrects JAMA article that misidentifies illegal drugs as dietary supplements

Products adulterated with undeclared drugs are not dietary supplements

In a letter to the editor submitted to JAMA Open Network, American Herbal Products Association (AHPA) President Michael McGuffin stressed that the herbal products industry shares concerns about unapproved drugs masquerading as dietary supplements, as outlined in a recent article, but also highlighted that the authors mislead readers by failing to make a clear distinction between unlawful, misbranded drugs and legal dietary supplements.

AHPA launches sustainability subcommittee, formalizing ongoing efforts

Subcommittee to further AHPA’s ongoing efforts to ensure sustainable supplies of valuable botanicals

AHPA's Botanical Raw Materials Committee has launched a Sustainability Subcommittee to further AHPA’s ongoing efforts to ensure sustainable supplies of valuable botanicals. The subcommittee will be a vehicle for increasing awareness of sustainability issues and best practices, provide a forum to discuss and develop industry-wide standards, and promote existing sustainability initiatives throughout the industry.

Arizona Board of Pharmacy reportedly considers most dietary supplements to be nonprescription drugs

Board is pushing supplement companies that sell in the state to register as "wholesaler of nonprescription drugs"

The Arizona State Board of Pharmacy recently began interpreting its authority in a manner that implies that virtually every company that manufacturers or sells dietary supplements in the state will need to register as a nonprescription drug facility. If the board is successful and persistent in this approach, it could significantly disrupt dietary supplement business in the state.

AHPA requests pullulan be allowed in dietary supplement products labeled as organic

AHPA supports petition submitted by the Organic Trade Association (OTA) to request that pullulan be added to the National List

The American Herbal Products Association (AHPA) submitted comments yesterday to the National Organic Standards Board (NOSB) to request that pullulan continue to be allowed to be used in encapsulated herbs marketed as “made with organic [specified ingredients or food group(s)]” under the National Organic Program (NOP).
RSS
12345678

2019 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.